Suppr超能文献

1型糖尿病控制不佳时肾脏对血管加压素的抵抗

Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus.

作者信息

McKenna K, Morris A D, Ryan M, Newton R W, Frier B M, Baylis P H, Saito T, Ishikawa S, Thompson C J

机构信息

Beaumont Hospital, Dublin 9, Republic of Ireland.

出版信息

Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E155-60. doi: 10.1152/ajpendo.2000.279.1.E155.

Abstract

To investigate the hypothesis that diabetes induces nephrogenic diabetes insipidus, we studied the urine-concentrating ability in response to vasopressin (AVP) in 12 patients with insulin-dependent diabetes mellitus (IDDM) and 12 nondiabetic controls. Subjects were euglycemic-clamped, and after oral water loading, AVP was infused intravenously for 150 min. AVP induced a greater (P<0.001) rise in urine osmolality in controls (67.6+/-10.7 to 720+/-31.1 mosmol/kg, P<0.001) than in IDDM patients (64.3+/-21.6 to 516.7+/-89.3 mosmol/kg, P<0.001). Urinary aquaporin-2 concentrations after AVP infusion were higher in controls (611.8+/-105.6 fmol/mg creatinine) than in IDDM (462.0+/-94.9 fmol/mg creatinine, P = 0. 003). Maximum urine osmolality in IDDM was inversely related to chronic blood glucose control, as indicated by Hb A(Ic) (r = -0.87, P = 0.002). To test the hypothesis that improved glycemic control could reverse resistance to AVP, 10 IDDM subjects with poor glycemic control (Hb A(Ic) >9%) were studied before (B) and after (A) intensified glycemic control. Maximum urine osmolality in response to AVP increased with improved glycemic control (B, 443.8+/-49.0; A, 640.0+/-137.2 mosmol/kg, P<0.001), and urinary aquaporin-2 concentrations after AVP increased from 112.7 +/-69 to 375+/-280 fmol/mg creatinine (P = 0.006), with improved glycemic control. Poorly controlled IDDM is associated with reversible renal resistance to AVP.

摘要

为了研究糖尿病诱发肾性尿崩症这一假说,我们对12例胰岛素依赖型糖尿病(IDDM)患者及12名非糖尿病对照者对血管加压素(AVP)的尿液浓缩能力进行了研究。使受试者血糖正常钳制,口服大量水后,静脉输注AVP 150分钟。与IDDM患者(从64.3±21.6至516.7±89.3 mosmol/kg,P<0.001)相比,AVP使对照者(从67.6±10.7至720±31.1 mosmol/kg,P<0.001)的尿渗透压升高幅度更大(P<0.001)。AVP输注后,对照者尿水通道蛋白-2浓度(611.8±105.6 fmol/mg肌酐)高于IDDM患者(462.0±94.9 fmol/mg肌酐,P = 0.003)。如糖化血红蛋白A1c(Hb A1c)所示,IDDM患者的最大尿渗透压与慢性血糖控制呈负相关(r = -0.87,P = 0.002)。为了验证改善血糖控制可逆转对AVP抵抗这一假说,对10名血糖控制不佳(Hb A1c>9%)的IDDM受试者在强化血糖控制前后进行了研究。随着血糖控制改善,对AVP反应的最大尿渗透压升高(控制前,443.8±49.0;控制后,640.0±137.2 mosmol/kg,P<0.001),且AVP后尿水通道蛋白-2浓度从112.7±69升高至375±280 fmol/mg肌酐(P = 0.006)。血糖控制不佳的IDDM与对AVP的可逆性肾抵抗有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验